Your browser doesn't support javascript.
loading
[Research progress in gene therapy for Wilson's disease].
Tang, S; Bai, L; Zheng, S J.
Afiliação
  • Tang S; The First Unit, Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Bai L; The Fourth Unit, Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
  • Zheng SJ; The First Unit, Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Zhonghua Gan Zang Bing Za Zhi ; 29(1): 21-24, 2021 Jan 20.
Article em Zh | MEDLINE | ID: mdl-33541020
ABSTRACT
Wilson's disease (WD) is a kind of inherited single-gene autosomal recessive disorder in which mutations in the ATP7B gene cause copper excretion disorders. Drug therapy is currently the main treatment method for WD. Liver transplantation should be considered for poor drug response or acute liver failure. However, it faces problems such as medication adherence, adverse reactions and shortage of liver source. Gene therapy in WD may permanently correct abnormal copper metabolism, which is why it is the focus of current research. This article summarizes the research progress of WD around gene therapy vectors and CRISPR/Cas9 gene editing system.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular Limite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular Limite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China